Brian Mann
-
The Biden administration points to fentanyl as the major culprit for the increase in deaths. Officials unveiled a new one-year strategy to reduce the number of fatalities from drug overdoses. -
Companies that sold or distributed opioid medications face huge legal, financial and public relations peril. Critics say shareholders, not CEOs, will pay the price. -
Two dozen states had hoped to sue the owners of Purdue Pharma for their alleged role in the opioid crisis. But a federal bankruptcy has judge put the brakes on — again — until April 21. -
Attorneys, forensic analysts and other financial experts working for Purdue Pharma spent nearly two years looking for evidence of wrongdoing by the Sacklers. Critics want the findings made public. -
Under a bankruptcy plan filed late Monday, the OxyContin maker would pay $500 million up front, promising billions in future payments. Twenty-four states rejected the proposal. -
The CDC says hospitals saw a lot more emergency cases involving drug overdoses, as well as mental health crises and suicide attempts. Many emergency departments weren't ready. -
Lawmakers are blasting the nation's biggest drug makers and distributors for looking to use a pandemic tax-break loophole to write down losses coming from settlements linked to the opioid epidemic.
-
Black Americans with addiction face "pervasive and continuing systemic racism" and often struggle to gain access to treatments that prevent fatal overdoses.
-
Many drug rehab programs use aggressive sales techniques, price-gouge patients and provide substandard care. The system often pushes people struggling with addiction into debt, but not recovery. -
The state opened a mass vaccination site at Yankee Stadium in the Bronx on Friday and is working with Black pastors to overcome worries about vaccine safety.
